An America-First Healthcare Plan

2020-10-01Executive Order 13951
Signed by: Donald Trump
Share:

Headline: Federal Agencies Must Expand Healthcare Choices, Lower Costs, Increase Transparency

What it does: Agencies must maintain and expand existing actions to increase care options, lower costs, boost price transparency, address surprise billing, and advance drug approvals and medical innovations.

Real World Impact:
  • Expanded affordable prescription options through faster approvals and safe importation
  • Hospitals will be listed on Medicare.gov with prices and billing quality details
  • New protections to prevent unexpected out-of-pocket surprise medical bills
Topics: healthcare costs, drug pricing, price transparency, patient protections, medical innovation

Summary

This order directs federal agencies to maintain and build upon actions that expand healthcare choices, lower costs, and improve care. It asks health, labor, and treasury officials to speed approvals for generic and biosimilar drugs, help allow safe drug importation, increase price and quality information, and address surprise medical bills.

Patients, hospitals, drug makers, insurers, and veterans are affected. The goal is to make medicines more affordable, give patients clearer prices before care, reduce unexpected bills, and promote medical innovation.

Ask about this order

Ask questions about this executive order and its implications.

What agencies are affected by this order?

How does this order change existing policy?

What are the practical implications of this order?

Related Executive Orders